Kairos Ventures
www.kairosventures.comVCMatch tracks Kairos Ventures as an investor focused on AI/ML, Data Infrastructure, and Hardware companies, Pre-Seed and Seed rounds, United States and Global markets, and $150k to $20m check sizes. Upload your deck to compare your startup against the full private matching profile.
Check Size
$150k to $20m
Focus Areas
Geography
United States and Global
Investment Thesis
Kairos Ventures focuses on commercializing world-class scientific discoveries by investing early in ideas, patents and businesses emerging from leading universities and scientists. They aim to move technologies into viable companies “as quickly as possible,” providing capital, hands-on support and an extensive operational network while preserving founder ownership and working closely with scientific founders to deliver large societal impact.
Is Kairos Ventures right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
Kairos Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in AI/ML, Data Infrastructure, Hardware, and Semiconductors, especially across United States and Global, with public check-size signals around $150k to $20m.
Focus statement
They invest in early-stage, science- and technology-driven ventures spun out of top universities and research groups (biotech, deep tech, hardware and applied sciences), generally deploying between $150,000 and $20 million and partnering with academic institutions to commercialize discoveries.
Value Add
- Explicit university and scientist focus: invests in "ideas, patents and businesses from the world’s top universities and scientists."
- Kairos Method / university partnership model: extends a proven method from a Caltech partnership to other universities (e.g., Cornell, Columbia).
- Broad operational support: provides legal, finance, marketing, operations, business development and HR services to early-stage portfolio companies.
- Founder-friendly stance: hands-on investor but strives to ensure "the founding team... retain the majority of the ownership in their companies."
- Cross-disciplinary team with entrepreneurial track record: team members who have "built, managed and sold companies" with "over 100 years of experience."
- Clear investment sizing and stage discipline: explicitly invests early/formative stages and specifies ticket sizes of "$150,000 and $20 Million."
Stage And Sector Fit
Portfolio Highlights
Tanvas
Hardware
Axial Biotherapeutics
Biotech
3D Bio Corporation
Biotech
Ready to find your perfect investor match?
Get Started Free